SoundBio is a highly innovative biotechnology company dedicated to the discovery, development and commercialization of novel biologics in the areas of oncology and immunological diseases to address unmet patient’s needs.
SoundBio is a highly innovative biotechnology company dedicated to the discovery, development and commercialization of novel biologics in the areas of oncology and immunological diseases to address unmet patient’s needs.
We are building a robust pipeline with our proprietary in-house ADICT platform, that enable us to develop highly differentiated antibodies against various disease targets with great potency and safety profiles.
-
DrugsTargetsIndicationsDiscoveryPreclinicalINDPhase IPhase IIPhase IIIState
-
View more
FTL008.16
5T4×4-1BB
Solid tumours
Phase I clinical trial
-
View more
FTL001
4-1BB
Solid tumours
Phase I clinical trial
-
View more
FTL004
CD38
MM/ Autoimmune
FDA IND secured
-
View more
FTL008.7
undisclosed
Solid tumours
-
DrugsTargetsMOATherapeutic AreasDiscoveryLead OptimizationPreclinicalIND
-
View more
FTL004
CD38
B and Plasma Cell Depletion
Autoimmune
-
View more
FTL024
CD38xBCMA xCD3
B and Plasma Cell Depletion
Autoimmune
-
View more
FTL032
BCMAxGPRC5D xCD3
B and Plasma Cell Depletion
Autoimmune
-
View more
FTL028
IL-4RaxTNF
Type 1 and Type 2 Pathways Blocking
Autoimmune
-
View more
FTL021
undisclosed
T cell Subset Depletion
I&I
-
View more
FTL022
undisclosed
T cell Subset Depletion
I&I
-
Sound Biopharmaceuticals
-
Harbour Mice
-
Product ipeline
-
Cooperation Mode
版权 © 2025 非同生物. 版权所有
蜀ICP备18014124号-1